F207-0504 Screening compound: methyl 4-oxo-3-({4-[(3-phenylpropyl)carbamoyl]phenyl}methyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazoline-7-carboxylate

F207-0504 Screening compound: methyl 4-oxo-3-({4-[(3-phenylpropyl)carbamoyl]phenyl}methyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazoline-7-carboxylate
F207-0504 Screening compound: methyl 4-oxo-3-({4-[(3-phenylpropyl)carbamoyl]phenyl}methyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazoline-7-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound F207-0504
methyl 4-oxo-3-({4-[(3-phenylpropyl)carbamoyl]phenyl}methyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazoline-7-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F207-0504

Molecular Formula

C27H25N3O4S (C27 H25 N3 O4 S)

Compound Name

methyl 4-oxo-3-({4-[(3-phenylpropyl)carbamoyl]phenyl}methyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazoline-7-carboxylate

IUPAC name

methyl 4-oxo-3-({4-[(3-phenylpropyl)carbamoyl]phenyl}methyl)-2-sulfanylidene-1234-tetrahydroquinazoline-7-carboxylate

SMILES

COC(c(cc1)cc(NC(N2Cc(cc3)ccc3C(NCCCc3ccccc3)=O)=S)c1C2=O)=O

InChI

InChI=1S/C27H25N3O4S/c1-34-26(33)21-13-14-22-23(16-21)29-27(35)30(25(22)32)17-19-9-11-20(12-10-19)24(31)28-15-5-8-18-6-3-2-4-7-18/h2-4,6-7,9-14,16H,5,8,15,17H2,1H3,(H,28,31)(H,29,35)

InChI Key

SGLLAQKZFNDMQD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD11994028

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

487.58

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.956

Distribution Coefficient, logD

4.955

Water Solubility, LogSw

-4.62

Polar Surface Area

72.747

Acid Dissociation Constant (pKa)

9.91

Base Dissociation Constant (pKb)

-2.66

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.50

F207-0504 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with F207-0504 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F207-0504?
Check Price and Availability of F207-0504, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F207-0504 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F207-0504
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F207-0504
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F207-0504 available by request